Bispecific Antibodies Across Hematologic Malignancies: Nursing Considerations and Skill-Based Training for Clinical Integration

Improve your knowledge on bispecific antibodies in hematologic malignancies, including essential information on their mechanisms of action, clinical considerations, and safety profiles. This on-demand webcast with accompanying slides includes faculty insights on bispecific antibodies for multiple myeloma and B-cell lymphoma, highlighting current evidence, treatment pathways, and strategies for effective patient management.

Share

Program Content

Activities

Bispecific Antibodies Across Hematologic Malignancies
Bispecific Antibodies Across Hematologic Malignancies: Nursing Considerations and Skill-Based Training for Clinical Integration
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 25, 2024

Expires: September 24, 2025

Faculty

cover img faculity

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Department of Hematology and Medical Oncology
Cleveland Clinic Taussig Cancer Institute
Member, Population and Cancer Prevention Program
Case Comprehensive Cancer Center
Cleveland, Ohio

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an education grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC